Stat: Vinay Prasad's FDA Speech: Praises Staff, Embraces Evidence In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his admiration for agency ...

On track for first patient dosing of SER-252 in Phase 1b clinical trial in advanced Parkinson's disease in Q4 2025 Strengthened balance sheet with recent financing Advancing innovative POZ Platform ...

Analysing the gene activity of every single bacterial cell in a colony? A new technique of single-cell transcriptomics ...

Biogen has made a further push into RNA-based drug discovery via a collaboration with Envisagenics, which applies artificial intelligence RNA sequencing data to discover new drug targets and ...

You’re all signed up! Want more of our free, weekly newsletters in your inbox? Let’s get started. The Tampa Bay Times e-Newspaper is a digital replica of the printed paper seven days a ...

In a statement to the Times after her resignation, The Post’s then-editorial page editor, David Shipley, thanked Telnaes for her service but rejected her suggestion that he yanked the cartoon to ...

Admit I’ve Photoshopped the photo/cartoon topping this post. Had too many options on what label to Photoshop onto Trump’s fingers, from Despot, Dictator, Authoritarian... If you purchase a ...

CLEVELAND, Ohio-- During his cabinet-kow-tows-to-the-crown meeting, King Donald Trump sounded like Scrooge and grimaced like the Grinch that children might have to make do with just two dolls for ...

Based on the correspondence I receive from readers, editorial cartoons are divisive. Some of the e-mails convey criticism or offence. Others, praise for The Globe’s cartoonists, David Parkins ...

RNA sequencing refers to techniques used to determine the sequence of RNA molecules. It includes high-throughput shotgun sequencing of cDNA molecules obtained by reverse transcription from RNA ...

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox. From our morning news briefing to a weekly Good News Newsletter, get the ...

The two companies have been working together since 2019 to develop multiple RNA interference (RNAi) candidates for disorders such as non-alcoholic steatohepatitis (NASH), type 2 diabetes ...